Life-Threatening Bleeding in Patients Presenting to the ED: Indications, Therapy and Reversal Agents - Day 1

 

EMCreg

Day 1
Wednesday, May 15th, 2019
12:00 p.m. – 1:00 p.m.
Mirage Events Center C1
**Lunch Provided**

Faculty

Greg J. Fermann, MD – University of Cincinnati
Charles V. Pollack, MD – Thomas Jefferson University 
Joshua M. Kosowsky, MD – Brigham and Women’s Hospital/Harvard University 
Opeolu Adeoye, MD – University of Cincinnati EM/Neurocritical Care 
W. Brian Gibler, MD – University of Cincinnati(Moderator)

This symposium will describe the indications for anticoagulation, pharmacologic agents and reversal agents in the Emergency Department and ICU and the treatment of patients with severe bleeding, including intracranial and intraspinal bleeding. This is the 1sthour of a 2-hour symposium. This hour includes four (4) ten (10) minute presentations followed by a 20-minute panel discussion and Q & A with attendees.

Learning Objectives:

Emergency Physician attendees will able to: 

  • Describe various oral anticoagulants including the vitamin K antagonist warfarin, Factor IIa and Factor Xa inhibitors and their indications for patients with DVT/PE and Atrial fibrillation/Stroke
  • Interpret the Severe Bleeding Management Algorithm for the anticoagulated patient
  • Describe the process for the reversal of anticoagulant effects for patients with life-threatening bleeding who present to the ED
  • Describe the management of anticoagulated patients presenting to the ED with intracranial and intraspinal bleeding

Accreditation Statement:

The University of Cincinnati College of Medicine Office of Continuing Medical Education is accrediting this 1 hour symposium for 1 (one) hour of Category 1 ACCME credit.

Disclosures

Nothing to disclose